Projects funded by the NCN
Dual-acting 5-HT6/5-HT7 receptor antagonists: exploring beneficial effects for the treatment of neurodegenerative disorders
2025/57/N/NZ7/04187
Keywords:
5-HT6 receptor 5-HT7 receptor glioprotection inverse agonist neutral antagonist Alzheimer's disease neurodegenerative disorders
Descriptors:
- NZ7_07:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 24 - announced on 2025-03-17
Amount awarded: 209 962 PLN
Project start date (Y-m-d): 2026-02-16
Project end date (Y-m-d): 2029-02-15
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.